US stock · Healthcare sector · Biotechnology
G
Geron Corporation
GERN3.62
USD
+0.02
(+0.56%)
After Hours Market
-8.37P/E
-12Forward P/E
-0.40P/E to S&P500
1.842BMarket CAP
- -Div Yield
Google Trends
Recent Reddit Comments
Nothing found
Recent Tweets
0
0
11
$GERN - Geron's Data Allows Development Of Several Catalysts. https://t.co/Cm98YlGFV2 #finance #investing #economy
0
2
2
4
0
1
$OCGN DONT chase the great news. They will just naked short it down later
always the same pattern
ALSO like $GERN watch for the quick 2ndary. They naked short into the great news FRAUD ST Plus the warrants
https://t.co/Z9TebBUVST
2
1
14
DEMO - $GERN Trying to have no excuses not to stay active in the market. I've put way to much heart and soul into this to fade away because of delayed funding. Wishing everyone the best this year!! https://t.co/1b9HGSnv9U
6
1
53
1
1
4
$GERN is moving. Waiting for another breakout. https://t.co/PSkXsrqino
0
0
2
$GERN - Geron: The First Success Story Of The New Year. https://t.co/if2mihKBVA #stockmarket #trading #finance
0
2
5
$GERN
-no gap stats, no baggies
-high IO of 50%
-active warrants, s3 for 175m, atm for 79m
@FlashSec #DayTrading https://t.co/0UpeJ3OjHU
1
0
3
When you have a big short trying everything to cover. Fake news!! $gern
0
2
4
Geron $GERN, biotech that once sparked talk of immortality, finally gets a (more modest) success https://t.co/63IGrnDFk5 via @Jasonmmast
7
10
20
$GERN it's been a long journey since 2018 let the results be good 🤞🤞🤞🤞
1
1
7
$GERN we are now at 3 sticks https://t.co/FsKGlZc5oJ
1
0
1
$GERN (+15% AH) Ph 3 Data Tomorrow AM 🗞️
IMerge Phase 3 trial
• imetelstat [GRN163L] (telomerase inhibitor)
• Lower risk myelodysplastic syndromes (MDS)
Will host a conference call to discuss top-line results 8:00 a.m. ET.
0
5
10
$GERN Announces Conference Call for Top-Line Results from IMerge Phase 3 January 4. Buckle up folks https://t.co/28TDrnBmKA
1
4
3
2
3
13